$UAMY Balance Sheet | Understand Stock

$UAMY

$3.31 +$0.46 (16.14%) Close

$UAMY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q3 FY2021 As of Sep 30, 2021
ASSETS
Cash and cash equivalents
Certificates of deposit
Cash and cash equivalents
Investment securities held to maturity
Investment in debt securities held to maturity
Accounts receivable, net
Prepaid expenses
Inventories (Note 6)
Government grant receivable
Inventories
Prepaid expenses and other current assets
Current assets held for sale (Note 12)
Note receivable
Total current assets
Property, plant and equipment, net
Operating lease right-of-use assets
Investment securities held to maturity - noncurrent
Restricted cash for reclamation bonds
Non-current assets held for sale (Note 11)
Other assets
Noncurrent assets held for sale (Note 12)
Investment in debt securities held to maturity - noncurrent
Investment in equity securities
Investment in joint venture
Restricted cash
Other assets, net
Total assets

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Checks issued and payable
Accounts payable
Payable to related parties
Accrued liabilities
Non-related party
Directors
Total non-related party
Total accrued liabilities
Accrued liabilities - officers and directors
Notes payable to bank (Note 7)
Export tax assessment payable (Note 11)
Hillgrove advances payable (Note 12)
Accrued liabilities - directors
Royalties payable
Dividends payable
Current portion of operating lease liabilities
Current portion of long-term debt
Current liabilities held for sale (Note 12)
Total current liabilities
Long-term debt, net of current portion (NOTE 8)
Long-term debt, net of current portion (Note 9)
Stock payable to directors
Noncurrent operating lease liability

Operating lease liabilities, net of current portion
Long-term debt, net of current portion
Hillgrove advances payable (Note 12)
CARES Act note payable (Note 14)
Stock payable to directors for services
Asset retirement obligations and accrued reclamation costs (NOTE 7)
Stock payable to directors
Asset retirement obligations
Noncurrent liabilities held for sale (Note 12)
Total liabilities
STOCKHOLDERS' EQUITY
Preferred stock
Series A Preferred Stock
Series B
Series C
Series D Preferred Stock
Common stock, $0.01 par value, 250,000,000 shares authorized; 150,521,555 and 140,042,270 shares issued, respectively
Treasury stock (1,050,186 and 149,639 shares of common stock at cost, respectively)
Additional paid-in capital
Shares to be returned to treasury
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments